WASHINGTON — Facing last-minute liberal resistance in Congress, the drug industry is bracing for an increase in its share of the cost of the proposed health care overhaul beyond the $80 billion over 10 years that it had negotiated with the White House, industry lobbyists say.
via Drug Industry Girds for Rise in Its Share of Overhaul – NYTimes.com.